Ovarian function in female survivors of high-risk neuroblastoma.
Lauren Jimenez-KurlanderAmelia DeRosaCaroline E KostrzewaChaya S MoskowitzKimberly BogardusZoltan AntalSuzanne L WoldenMichael P LaQuagliaEllen M BasuFiorella Iglesias CardenasKim KramerBrian H KushnerNai-Kong V CheungShakeel ModakDanielle Novetsky FriedmanPublished in: Pediatric blood & cancer (2024)
Ovarian dysfunction is prevalent in female high-risk neuroblastoma survivors, especially after ASCR. Longitudinal follow-up of larger cohorts is needed to inform counseling about the risk of impaired ovarian function after neuroblastoma therapy.